• Nursing Exam Prep Made Easy — Get
Your Documents Today!
NURSE WISEMAN 2026/2027 MEDICINE
,Nurs 615 Pharm Exam 1 – Maryville
Nurse Practitioners Review Exam
(Latest 2026/ 2027 Update) 100%
Verified Questions & Answers |
Grade A+
How does hypoalbuminemia affect the process of
prescribing? - ANSWER✅✅Low albumin = more free
drug (bc the drug can't bind to albumin aka protein) =
increased adverse effects
What is a Black Box Warning: - ANSWER✅✅is
considered a contraindication to administer that drug.
What is the drugs half-life? - ANSWER✅✅Half-life
specifically means the amount of time it takes for an
administered drug to be halfway cleared from the system.
Peak of action: - ANSWER✅✅the time between drug
administration and maximum concentration of drug in
the blood stream. Best therapeutic effect.
,Duration of action: - ANSWER✅✅the time between
onset of action and metabolism of drug below the
minimum needed for an effect. The length of time you
have the drug in your system.
According to the WHO what is the first step in the
prescribing process? - ANSWER✅✅The first step is
to define the patient's problem
The second step is to - ANSWER✅✅specify the
therapeutic objective
The third step is to - ANSWER✅✅choose which drug
or treatment is needed.
Step 4 of the WHO approach: - ANSWER✅✅Start
the treatment
Step 5 of the WHO approach: - ANSWER✅✅Educate
the patient
Step 6 of the WHO approach: - ANSWER✅✅Monitor
the treatment
, Phase 1 of drug development: - ANSWER✅✅The
drug is tested on healthy volunteers
Phase 2 of drug development: - ANSWER✅✅trials
with people who have the disease for which the drug is
thought to be effective
Phase 3 of drug development: - ANSWER✅✅Large
numbers of patients in medical research centers receive
the drug in phase 3. This larger sampling provides
information about infrequent or rare adverse effects. The
FFA will approve a new drug application if phase 3 studies
are satisfactory.
Phase 4 of drug development: - ANSWER✅✅This
phase is voluntary and involves postmarket surveillance
of the drug's therapeutic effects at the completion of
phase 3. The pharmaceutical company receives reports
from doctors and other health care professionals about
the therapeutic results and adverse effects of the drug.
Some medications, for example, have been found to be
toxic and have been removed from the market after their
initial release.